Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Sequenom to Develop Third-Generation Nanopore-Based Single Molecule Sequencing Technology

Published: Tuesday, September 25, 2007
Last Updated: Tuesday, September 25, 2007
Bookmark and Share
Company Acquires Rights to DNA and RNA Readout Technology That Holds Potential for Cost-Effective and Ultra Rapid Human Genome Sequencing

Sequenom, Inc. has announced that it plans to develop a third-generation single molecule nucleic acid analysis technology based on exclusive license rights from Harvard University that covers a readout system technology for single DNA molecules based on simultaneous optical probing of multiple nanopores.

This technology recently received a National Institutes of Health (NIH) three-year award for the development of a next-generation sequencing technology aiming at a sub-thousand dollar genome.

Nanopore-based single molecule readout technology is a method that can detect a single strand of DNA as it passes through a pore that is more than a thousand times smaller than the diameter of a human hair and should enable ultra-high throughput DNA analysis such as sequencing, genotyping, and RNA and epigenetic analysis on a whole genome scale.

Financial terms of the agreement include up-front fees, milestone payments and royalties on future product sales.

"We are excited to have an opportunity to collaborate with such world class institutions and researchers in developing this potentially disruptive technology," said Harry Stylli, Ph.D., Chief Executive Officer of Sequenom.

"This technology should enable us to provide highly competitive large-scale genotyping, and RNA analysis and ultimately sequencing-based solutions to the market.

Our MassARRAY® platform is the leading fine mapping/translational solution and as we continue to expand and develop new applications for the platform, we also plan to expand our market penetration into the complementary whole genome analysis/single molecule sequencing markets with this potentially redefining nanopore technology.

Near term we expect this nanopore technology to deliver large scale genotyping solutions and long term we believe it has the potential to provide a commercially viable, rapid, sub-thousand dollar human genome sequencing solution."

"As nucleic acid sequencing costs become progressively lower, it will become cost effective to replace more aspects of DNA and RNA analysis by sequencing," stated Charles Cantor, Ph.D., Chief Scientific Officer of Sequenom.

"It is strategically important for Sequenom to be able to offer customers a cost-effective sequencing option and we do not believe the new second-generation sequencing methods will achieve the needed cost effectiveness," Dr. Cantor added.

"The synergy between the required manpower skills needed to develop nanopore sequencing and our current science and engineering expertise behind our MassARRAY technology is noteworthy.

Optimizing molecular biology tools for sample preparation and optimizing software tools for fast signal processing are key requirements for nanopore sequencing and Sequenom currently has great strength and experience in these areas."

"This Nanopore-based single molecule readout technology combines solid-state nanopores and optical detection to overcome the major challenges associated with directly measuring electrical current differences between traversing molecules, challenges such as the need to wire every single pore and the very high flow rate and electrical noise that can prevent discrimination between single bases.

This technology also avoids the uncertainties associated with the development of new chemical compounds required in other approaches and does not rely on the relatively slow enzymatic incorporation of nucleotides allowing for an extremely high-throughput of millions of bases per second," said inventor and development partner Amit Meller, Ph.D., Associate Professor at the Boston University Department of Biomedical Engineering. Dr. Meller invented the technology while at the Rowland Institute of Harvard University.

"We are delighted that Sequenom will be developing this technology, which may enable the coming revolution in personalized medicine, which will greatly benefit the public's health," said Isaac Kohlberg, Chief Technology Officer of Harvard University and head of Harvard's Office of Technology Development.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Sequenom Announce New Data from a Collaborative Project with The Chinese University of Hong Kong
Next-generation noninvasive diagnostic technology shown to detect fetal down syndrome in first trimester of pregnancy.
Tuesday, December 02, 2008
Scientific News
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Biologists Induce Flatworms to Grow Heads and Brains of Other Species
Findings shed light on role of a new kind of epigenetic signaling in evolution, could yield clues for understanding birth defects and regeneration.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
The Secret Behind the Power of Bacterial Sex
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
Farming’s in Their DNA
Ancient genomes reveal natural selection in action.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos